Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A

This publication has 27 references indexed in Scilit:

• Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features
  Cancer Science, 2006
• Neuroendocrine Differentiation in Prostate Cancer: Implications for New Treatment Modalities
  Published by Elsevier ,2004
• Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines
  The Prostate, 2004
• Protein Gene Product 9.5 (PGP 9.5) Is Not a Specific Marker of Neural and Nerve Sheath Tumors: An Immunohistochemical Study of 95 Mesenchymal Neoplasms
  Laboratory Investigation, 2003
• Interaction and colocalization of PGP9.5 with JAB1 and p27Kip1
  Oncogene, 2002
• Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues
  Cancer Letters, 2001
• The Neuronal Marker Protein Gene Product 9.5 (PGP 9.5) Is Phenotypically Expressed in Human Breast Epithelium, in Milk, and in Benign and Malignant Breast Tumors
  DNA and Cell Biology, 1994
• Characterization of high‐affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC‐3 and DU‐145: Internalization of receptor bound ¹²⁵I‐(Tyr⁴) bombesin by tumor cells
  The Prostate, 1994
• Neuronal protein gene product 9.5 (IEF SSP 6104) is expressed in cultured human MRC‐5 fibroblasts of normal origin and is strongly down‐regulated in their SV40 transformed counterparts
  FEBS Letters, 1991
• Molecular cloning of cDNA coding for human PGP 9.5 protein
  FEBS Letters, 1987